Navigation Links
BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Date:1/28/2008

FRANKLIN LAKES, N.J., Jan. 28 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it would present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on Thursday, February 7, 2008 at 10:20 a.m. (ET).

The live webcast of BD's presentation can be accessed from the BD corporate website at http://www.bd.com/investors and will be available for replay through Thursday, February 14, 2008.

BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people's health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit http://www.bd.com.


'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
5. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
6. AtriCure to Present at Roth Capital Partners 2007 New York Conference
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. MDS to Present at Thomas Weisel Partners Healthcare Conference
9. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
10. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/3/2008)...- Inc. Magazine recently included,Connolly Consult...ing,private companies in the country. The list is ...segment of the economy -- America,s,independent-mi...ies,represent the backbone of the U.S. economy., ...03/NY36880LOGO ), Connolly Consulting,s consiste...
(Date:10/3/2008)... Discrimination; Recognizes,Importance of Mental H.../PRNewswire-USNewswire/ -- Mental Health,America t...approval of a,mental health parity legislation tha...ion against Americans with mental health and subst...lans., The legislation, which recognizes the impo...
(Date:10/3/2008)...search Foundation(R) Collection of, Bouquets to T...Research, LOS ANGELES, Oct. 3 /PRNewswire/ -- Tel...g only hand-arranged, hand-delivered floral,arrang...nth-long,collaboration with The City of Hope, John... Cancer Center in southern California and national...
(Date:10/3/2008)...- As the population ages, a big,question employers...e the,financial crunch of an illness?", In most c...eck to,paycheck and now need two incomes to provid... spouses becomes critically ill and unable to work...ut the healthy,employee/spouse is strained by the ...
Breaking Medicine News(10 mins):Health News:Connolly Consulting Makes the 2008 Inc. Magazine's List of America's 5000 Fastest Growing Companies 2Health News:Mental Health America Hails Approval of Federal Parity Legislation 2Health News:Mental Health America Hails Approval of Federal Parity Legislation 3Health News:Teleflora and Nationally Recognized Hospitals to Honor Women Battling Breast Cancer 2Health News:Teleflora and Nationally Recognized Hospitals to Honor Women Battling Breast Cancer 3Health News:Can Your Employees Survive the Financial Crunch of an Illness? 2
...nd to be effective in reducing chest pain, not ass...f patients with chest pain have no identifiable ca...e efforts by cardiologists, they continue to be se...icularly, young women seem be more prone to this c...
...that was conducted by the London School of Hygiene... pandemic across Europe, it was found that serious...tween countries existed. // The Czech Republic, It...gal were the least prepared. It is necessary that...
...d the largest outbreak of mumps over the past two ... country since 1988 // , is believed to have begun... federal officials reported yesterday that the out...ng to latest information from the U.S. Centres for...
...Queen's University and the University of Pennsylva... for drugs like Celebrex and Vioxx, administered f...otential risk of triggering a heart problem Co-aut...istry and Physiology at Queen's, and Canada Resear...
Other Medicine News:Health News:Non-Cardiac Chest Pain Can Be Treated By Hypnotherapy 2Health News:Joint Effort among Various Nations to Tackle Bird Flu 2Health News:Mumps Outbreak In The US 2Health News:Mumps Outbreak In The US 3
(Date:10/3/2008)...e newest study site, PHILADELPHIA, Oct. 3 /PRNews...ladelphia today received a contract to manage a ne...ldren,s Hospital will manage local,participation, ...ty, New,Jersey. The study is funded by the Nationa... approximately 1,000 families in Burlington,County...
(Date:10/2/2008)...f Rosetta Genomics, microRNA-based,Test, miRview(T...n Squamous non Small Cell Lung Cancer, With C...view(TM) Technology First Approved for Clinical us... Molecular Pathology Lab ... to Launch miRview(TM) Squamous Later This Ye...
(Date:10/2/2008)...stCall/ - AEterna Zentaris Inc.,(NASDAQ: AEZS ; T...ed on,endocrine therapy and oncology, today report... recruitment for its Phase 2 trial in ovarian canc...hormone (LHRH) agonist,linked to doxorubicin. The ...uitment was taken following recent first stage dat...
(Date:10/1/2008)...ingual lozenge) developed to be the first sleep a... when patients awaken and have difficulty .../- Transcept Pharmaceuticals,Inc., a...announced today,that it has submitted a New Drug A...tration (FDA) for its lead product candidate, Inte...
Breaking Medicine Technology:The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 3Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 4Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 5AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 3AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 5Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 2Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 3Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 4Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 5Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 6Dawning Technologies Inc and Medical Automation Systems Inc to Develop a Business Partnership 20850 1Dawning Technologies Inc and Medical Automation Systems Inc to Develop a Business Partnership 20850 2Haemacure Reports on Financing Progress and Second Quarter Results 20846 1Haemacure Reports on Financing Progress and Second Quarter Results 20846 2Haemacure Reports on Financing Progress and Second Quarter Results 20846 3US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 1US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 2US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 3US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 4US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 5Vaccine may double survival in patients with deadly brain tumors 20841 1Vaccine may double survival in patients with deadly brain tumors 20841 2
Straight shafts with 1 x 2 teeth and serrated handle with polished finish.
Smooth 90 degree jaws with locking screw maintain proper stretch of sleeve for securing silicone bands.
Ergotec Vetriretinal Instrument System. Extra fine angled tips (3 mm). 20 gauge shaft tapering to 23 gauge, 10 mm from tip. Overall length from rear rotation knob to tip.
Ergotec Vetriretinal Instrument System. Ultra-fine 0.8 mm tips. Angled 40 degrees. 20 gauge shaft tapers to 23 gauge.
Medicine Products: